Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Fate Therapeutics Inc (NASDAQ: FATE) was $1.68 for the day, up 1.20% from the previous closing price of $1.66. In other words, the price has increased by $1.20 from its previous closing price. On the day, 10.13 million shares were traded. FATE stock price reached its highest trading level at $1.8 during the session, while it also had its lowest trading level at $1.6404.
Ratios:
Our analysis of FATE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.29 and its Current Ratio is at 8.29. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.25.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 20 ’24 when Redmile Group, LLC bought 341,633 shares for $1.66 per share.
Xu Yuan sold 633 shares of FATE for $2,678 on Aug 06 ’24. The Director now owns 8,669 shares after completing the transaction at $4.23 per share. On Aug 06 ’24, another insider, Xu Yuan, who serves as the Director of the company, bought 633 shares for $4.23 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 191341920 and an Enterprise Value of -6599520. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.40 while its Price-to-Book (P/B) ratio in mrq is 0.53. Its current Enterprise Value per Revenue stands at -0.491 whereas that against EBITDA is 0.04.
Stock Price History:
Over the past 52 weeks, FATE has reached a high of $8.83, while it has fallen to a 52-week low of $1.59. The 50-Day Moving Average of the stock is -33.58%, while the 200-Day Moving Average is calculated to be -57.26%.
Shares Statistics:
FATE traded an average of 2.59M shares per day over the past three months and 4412450 shares per day over the past ten days. A total of 113.88M shares are outstanding, with a floating share count of 97.96M. Insiders hold about 13.99% of the company’s shares, while institutions hold 89.11% stake in the company. Shares short for FATE as of 1732838400 were 11348453 with a Short Ratio of 4.38, compared to 1730332800 on 15902286. Therefore, it implies a Short% of Shares Outstanding of 11348453 and a Short% of Float of 11.4300005.
